Posted on 27/02/2017
For immediate release. March 02, 2017 – Worthing, United Kingdom. Rayner announced today that a selection of models in their Sulcoflex range of pseudophakic supplementary IOLs have received Chinese Food and Drug Administration (CFDA) approval and are to be launched in market in 2017. Rayner is the first manufacturer to make a supplementary IOL available to surgeons in
Posted on 15/02/2017
In 2016, 773 Rayner IOLs were used to restore the sight of some of Bangladesh’s poorest and most isolated people, according to the recent Annual IMPACT partner report. There were no complications found during post-operative follow up visi...
Posted on 31/01/2017
Phoenix Equity Partners ("Phoenix"), a leading UK middle-market private equity firm, today announces an investment in Rayner Surgical Group (“Rayner” or “the Company”) alongside the current management team...
Posted on 16/01/2017
For immediate release. Date: 16th January 2017 Rayner continues growth in 2017 with direct presence in Portugal. Following on from their European expansion in 2016 — direct entry into the Italian cataract market and direct entry into the Spanish cataract market — Rayner is pleased to announce its direct entry into the Portuguese cataract market. The entire Rayner IOL & injector portfolio,
Posted on 18/11/2016
Italian-speaking surgeons can now find a solution to their needs more efficiently and with greater ease thanks to the launch of an Italian translation of our global website. “Having recently announced our direct entry into Italy, it makes sense to offer surgeons an Italian translation of the Rayner website, joining our German, French and Spanish translations,” said
Posted on 4/11/2016
The honour of presenting the 2016 Rayner Medal Lecture was awarded to Dr Warren Hill and as UKISCRS Secretary Satis...
Posted on 31/10/2016
To mark the recent Annual National Customer Service Week Event, our passionate Customer Service Manager, Sue Wheatley, brought this idea to life through immersing Rayner staff across various areas of the business in the Rayner Customer Experience. Employees were given the opportunity to shadow a member of the nine strong international Customer Service team for
Posted on 3/10/2016
Rayner acquires Moorfields Pharmaceuticals October 3, 2016 – Worthing, United Kingdom. Rayner, the pioneering manufacturer of intraocular lenses for cataract surgery, announced today that it has acquired Moorfields Pharmaceuticals. The acquisition closed September 30, 2016. Acquisition details Rayner has acquired Moorfields Pharmaceuticals from Moorfields Eye Hospital NHS Foundation Trust for an undisclosed price, for the
Posted on 20/09/2016
The new-look Rayner booth -- designed specifically with RayOne® demos in mind -- was inundated with traffic. Surgeons clamored to experience the highly anticipated, fully preloaded IOL injection system at the recent XXXIV Congres...
Posted on 1/09/2016
For immediate release. Date: 1st September, 2016 The Smallest Fully Preloaded IOL Incision. Rayner set to launch RayOne at the Upcoming ESCRS Following the recent receipt of CE mark approval, Rayner are proud to announce the launch of RayOne: their fully preloaded IOL injection system to be unveiled at the upcoming ESCRS in Copenhagen. This flagship launch is